Dr. Williams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Department of Radiation Oncology
1500 East Duarte Road
Duarte, CA 91010Phone+1 626-301-8247Fax+1 626-218-5334
Education & Training
- University of MichiganResidency, Radiation Oncology, 2006 - 2011
- University of MichiganInternship, Internal Medicine, 2006 - 2007
- Albert Einstein College of MedicineClass of 2006
Certifications & Licensure
- CA State Medical License 2021 - 2025
- OH State Medical License 2011 - 2021
- MI State Medical License 2006 - 2013
- American Board of Radiology Radiation Oncology
Clinical Trials
- Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer Start of enrollment: 2021 Dec 06
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 258 citationsExtended Survival and Prognostic Factors for Patients With ALK-Rearranged Non–Small-Cell Lung Cancer and Brain MetastasisKimberly L. Johung, Norman Yeh, Neil Desai, Terence M. Williams, Tim Lautenschlaeger
Journal of Clinical Oncology. 2016-09-19 - 116 citationsEfficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Ra...Matthew H G Katz, Qian Shi, Jeff Meyers, Joseph M Herman, Michael Chuong
JAMA Oncology. 2022-09-01 - 16 citationsIncreasing neutrophil-to-lymphocyte ratio following radiation is a poor prognostic factor and directly correlates with splenic radiation dose in pancreatic cancer.Adam R. Wolfe, Michael Siedow, Ansel Nalin, Dominic DiCostanzo, Eric D. Miller
Radiotherapy and Oncology. 2021-05-01
Press Mentions
- City of Hope Orange County Celebrates 100th and 101st Patients Treated with County’s Most Advanced Radiation Oncology TechnologyNovember 12th, 2024
- RefleXion Receives FDA Clearance for SCINTIX Biology-Guided Radiotherapy; Cutting-Edge Treatment Applicable for Early and Late-Stage CancersFebruary 2nd, 2023
- Track and TreatJune 15th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: